Propacetamol
- Level
- Commodity
- Parent
- 51142000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142033This classification denotes an analgesic and antipyretic with the molecular formula C14H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5CHW4JMR82, chemically known as n,n-diethylglycine, ester with 4-hydroxyacetanilide but generally known as propacetamol, which bears US NIH Compound Identifier 68865. European Medicines Agency schedules Propacetamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10093MIG. The term PROPACETAMOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules propacetamol in its Anatomical Therapeutic Chemical (ATC) Classification. PROPACETAMOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule propacetamol under HS 29242995 and SITC 51479. As of Q4 2014, PROPACETAMOL remains the US FDA Preferred Term for this commodity. Propacetamol bears US NLM identifiers UMLS ID C0084186 and NCI Concept Code C75081. SMILES: O(C(=O)CN(CC)CC)C1CCC(NC(=O)C)CC1.
Same parent
Under 51142000 · 31Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.